Back
Insmed Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
INSM
Insmed
Last Price:
$71.16
Seasonality Move:
13.19%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and INSM is experiencing slight buying pressure.
Insmed Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 70.51 | Buy |
20-day SMA: | 69.92 | Buy |
50-day SMA: | 74.83 | Sell |
200-day SMA: | 73.8 | Sell |
8-day EMA: | 70.33 | Buy |
20-day EMA: | 71.07 | Buy |
50-day EMA: | 73.07 | Sell |
200-day EMA: | 68.55 | Buy |
Insmed Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.2 | Sell |
Relative Strength Index (14 RSI): | 49.28 | Sell |
Chaikin Money Flow: | 907397 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (67.77 - 75.07) | Sell |
Bollinger Bands (100): | (69.65 - 78.77) | Sell |
Insmed Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
INSM Technical Analysis vs Fundamental Analysis
Insmed Stock Info
Market Cap:
12.9B
Price in USD:
71.40
Share Volume:
1.8M
Insmed 52-Week Range
52-Week High:
84.91
52-Week Low:
21.92
Sell
47
Insmed (INSM)
is a Sell
Insmed Share Price Forecast
-
What is the Insmed stock price today?The Insmed stock price is 71.40 USD today.
-
Will INSM stock go up or go down?Insmed> share price is forecast to RISE/FALL based on technical indicators
-
Is Insmed overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Insmed is overvalued.
Is Insmed Stock a Buy?
Fundamental Analysis of Insmed
Is Insmed a good investment?
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $1.80 per share.
* Insmed stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.